Archives: Speakers

Matt is responsible for defining and leading the product strategy for ERT’s digital patient product line, with a focus on direct to patient enablement in both post approval research and patient support. Matt has spent the last 12 years leading teams and innovating products in both the clinical research and commercial healthcare settings to reduce patient burden of participation and to support patients in their healthcare journey.  Most recently, Matt was Global Head of Patient Engagement for ICON’s Commercialization & Outcomes division and, prior to that, Head of Direct to Patient Research (Virtual Trials) at IQVIA.

Jorge Garcia Perez is VP Sales and Marketing at Lactips. Economist and head of Research chair, he has significant experience in complex sales. Having worked as a consultant for the European Union working with technology companies in Spain, Finland, Portugal, Italy, France, he joined Lactips in 2018.

Experienced Chief Operations Officer and Government Affairs professional with a demonstrated history of working in the healthcare industry, security field and public sector. Skilled in Operations Management, Government, Entrepreneurship, Legal Management and Strategy. American Israeli strong legal professional with a Bachelor of Laws (LL.B.) IDC Herzliya.

Isaac Israel has served as Kitov’s Chief Executive Officer and a member of the board since 2012. Prior to joining Kitov, Mr. Israel founded BeeContact (formerly TASE: BCNT) and served as CEO from 2001 to 2007. Mr. Israel has served as owner and founding CEO of Uneri Capital, a capital market consulting firm specializing in healthcare, since 2008. He serves on the board of various public and private healthcare corporations, including chairman of the board of NextGen Biomed, which is traded on the TASE.

Moshe has been the President and CEO of 3QBD since 2006. Moshe’s team are bringing a new Technology to the Bio-Diagnostic market, with some of their 1st applications include OBS and Gyn. Diagnosing the Vaginal Flora in less than 90 seconds. 3QBD detect: BV, Trichomoniasis, Candida Albican, Infections caused by pathogens. simultaneously by one test
We are looking for Distributors in Europe specially East Europe.

David has been the CEO of Dali Medical since 2003. Dali Medical develop Innovative Injectable Drug Delivery Devices – from product concept to regulatory approval and commercialization. Their R&D activities include Developing novel concepts for auto-injectors and Safe Auto-Needles for self-administration of injectable drugs and biologics, bringing these concepts from a general idea to a commercially available device through and Technology transfer to external contract manufacturers and subcontractors both in Israel and internationally

I am a M.Sc. graduate in life sciences and Bbiotechnology (the Hebrew University of Jerusalem, Israel). After graduating’ I have acquired vast experience in the biomed industry and research and development of innovative botanical products.

For the past six years, I have served as R&D, Quality and Vocational Training Director in the Israeli Ministry of Health’s Medical Cannabis Agency (IMCA).  There, I took a major part in designing the policy and regulation for the emerging medical cannabis industry, including writing the clinical methodology and quality procedures for medical cannabis products.

Currently, I am the Head of the Medical Cannabis Clinical Research Center at the Chaim Sheba Hospital, Tel Hashomer, Israel; and an academic coordinator of the “cannabis for medical and research” course in the School of Graduate Studies, Sackler Faculty of Medicine, Tel Aviv University.

With 15 years of experience in media and marketing, Neasa has helped global Travel businesses navigate their next phase of growth. As the Head of Travel Marketing EMEA at Facebook, Neasa leads the EMEA travel team marketing efforts, driving awareness of the value Facebook, Instagram and Messenger brings to travel marketers.

Prior to joining Facebook Neasa worked in advertising and media helping clients with their marketing and advertising needs in both creative agencies and traditional media sales.

Magdalena Bogdańska is a Senior Data Scientist in Comarch, Financial Services Division. Within this role, she conducts research recognizing the possibilities of the new machine learning methodologies, evaluates new data science tools and implements POCs in the area of finance, banking & insurance industry. Before joining Comarch, Magdalena was a machine learning researcher in MIM Solutions. Previously, she led a reseach grant in applied mathematics.
Magdalena holds a PhD in mathematics from University of Warsaw, Poland and University of Castilla-La Mancha, Spain.